ESRRG and breast carcinoma: Thus we revealed a novel P4 elicited signaling cascade herein (P4-c-Myc-miR-320a- ARPP-19/ERRγ/c-Myc/Cyclin D1) to modulate tamoxifen-resistant breast cancer cells.